Skip to main content
. 2016 Sep 30;65(12):1523–1532. doi: 10.1007/s00262-016-1904-8

Table 2.

KIR and KIR–ligand genotype frequency

Number of patientsa %
2DL1 + 103 97
3 3
2DL2 + 52 49
54 51
2DL3 + 92 87
14 13
2DL5 + 51 48
55 52
2DS1 + 35 33
71 67
2DS2 + 50 48
56 52
2DS3 + 28 26
78 74
2DS4 + 102 96
4 4
2DS5 + 31 29
75 71
3DL1 + 103 97
3 3
3DS1 + 32 30
74 70 
HLA-C C1/C1 37 35
C1/C2 51 49
C2/C2 17 16
HLA-Bw4 + 74 70
31 30

a One of the 107 patients was excluded from KIR analyses; two of the 107 patients were excluded from KIR–ligand analyses